Browsing by Subject "radiotherapy"

Eye plaque radiotherapy is a treatment method of ocular tumors: A sealed radiation source is temporarily placed on the surface of the eye in day surgery. Compared to externally delivered conventional radiation treatments, more precisely targeted brachytherapy allows a higher dose in the target tissue while keeping the dose to healthy tissue relatively low. In Finland, all eye plaque treatments are centralised in Helsinki and brachytherapy of the eye is performed annually on approximately 70 patients. Patient specific anatomy takes into account determination of specific location and shape of the tumor in respect of radio-biologically critical structures of the eye. Until now, this has not been systematically modeled in dose calculation of eye plaque brachytherapy at HUS. The new version of Plaque Simulator, a 3D treatment simulation and modeling package for I-125, Pd-103, Ir-192 and Ru-106 plaque therapy of ocular tumors, enables importation and digitisation of patient imaging data (fundus imaging, CT and MRI) which consequently allows for systematically accurate estimation of dose distribution not only in the tumor but also in surrounding healthy tissues. The aim of this Master’s thesis is to prepare the new version of Plaque Simulator simulation and modeling package for clinical use in patient dose calculation at HUS. A comparison is done between the dose calculation method of the old and the new version of Plaque Simulator, and the dose calculation parameters as well as the plaque modeling parameters are reviewed. The function of the image-based dose calculation method is also tested with an anonymised patient treated for a tumor of a more peculiar shape. The absorbed dose to water on the central axis of the radiation source is measured experimentally for two individual I-125-seed along with Ru-106-CCB-, I-125-CCB-, and two I-125-COB-plaques. Experimental results are compared with the results obtained from Plaque Simulator. Individual I-125-seed is used to calibrate the detector at a distance of 10 mm, yielding to a calibration factor of 0.808. The use of the gold parameter in the dose calculation is justified, and a dosimetry modifier of Plaque Simulator is found to be 1.226 for I-125-plaques. Ru-106-plaque measurements are not calibrated, making them only relative. However, an excellent correspondence is observed between Ru-106-plaque dose calculations in Plaque Simulator and the manufacturer’s certificate. The measurements are normalized to the manufacturer’s certificate with a normalisation factor of 1.117.